top of page
Antibody Discovery Enabled by Deep Learning
deepCDR uses unique Deep Learning methods combined with its proprietary mammalian display process to select from a massively wide range of antibodies and rapidly identify candidates with the highest possible affinity and developability profiles.
Now part of Alloy Therapeutics. Learn More.
bottom of page